Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Cureus
|
March 30, 2022
Rapid Improvement Following Receipt of Infliximab in Steroid-refractory Durvalumab-Associated Grade 3 Pneumonitis
Sherri Huang, Aryanna Jordan, Dakota Jenneman, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|
August 22, 2018
The Efficacy and Safety of Rivaroxaban and Dalteparin in the Treatment of Cancer Associated Venous Thrombosis
Ateefa Chaudhury, Asha Balakrishnan, Christy Thai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 1, 2011
Venous thromboembolic disease
Michael B Streiff, Paula L Bockenstedt, Spero R Cataland, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 15, 2013
Venous thromboembolic disease
Michael B Streiff, Paula L Bockenstedt, Spero R Cataland, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 12, 2015
Cancer-Associated Venous Thromboembolic Disease, Version 1.2015
Michael B Streiff, Bjorn Holmstrom, Aneel Ashrani, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 19, 2021
Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Michael B Streiff, Bjorn Holmstrom, Dana Angelini, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 5, 2024
Cancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Michael B Streiff, Bjorn Holmstrom, Dana Angelini, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 17, 2018
NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018
Michael B Streiff, Bjorn Holmstrom, Dana Angelini, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Cureus
|
March 30, 2022
Rapid Improvement Following Receipt of Infliximab in Steroid-refractory Durvalumab-Associated Grade 3 Pneumonitis
Sherri Huang, Aryanna Jordan, Dakota Jenneman, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|
August 22, 2018
The Efficacy and Safety of Rivaroxaban and Dalteparin in the Treatment of Cancer Associated Venous Thrombosis
Ateefa Chaudhury, Asha Balakrishnan, Christy Thai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 1, 2011
Venous thromboembolic disease
Michael B Streiff, Paula L Bockenstedt, Spero R Cataland, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 15, 2013
Venous thromboembolic disease
Michael B Streiff, Paula L Bockenstedt, Spero R Cataland, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 12, 2015
Cancer-Associated Venous Thromboembolic Disease, Version 1.2015
Michael B Streiff, Bjorn Holmstrom, Aneel Ashrani, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 19, 2021
Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Michael B Streiff, Bjorn Holmstrom, Dana Angelini, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 5, 2024
Cancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Michael B Streiff, Bjorn Holmstrom, Dana Angelini, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 17, 2018
NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018
Michael B Streiff, Bjorn Holmstrom, Dana Angelini, et al.
Page
of 1